Apimeds Pharmaceuticals US Inc
APUS | AMEX
$2.94
$0.00 (+0.17%)
Nov 2, 2026, 9:42 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
PE Ratio | -0.18 | -0.28 | -0.37 | -0.39 | -0.50 | -1.70 | -1.83 | -1.54 | -1.78 | -2.51 | -3.26 | -8.91 | -14.47 | -18.18 | -33.85 |
PEG Ratio | 0 | 0 | 0 | 0.01 | 0 | -0.06 | 0.29 | 0.06 | -0.03 | 0.05 | -0.01 | -0.04 | 0.32 | 1.31 | n/a |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 0.14 | 0.22 | 0.12 | 0.27 | 0.19 | -1.45 | -1.87 | -2.42 | -3.55 | -9.58 | 79.57 | 17.41 | n/a | n/a | -3.55 |
P/FCF Ratio | -1.06 | -2.50 | -1.99 | -0.43 | -0.50 | -5.19 | -3.46 | -2.60 | -2.39 | -2.88 | -4.04 | -8.26 | -73.14 | -88.10 | -127.08 |
P/OCF Ratio | -1.06 | -2.51 | -2 | -0.43 | -0.50 | -5.19 | -3.46 | -2.60 | -2.39 | -2.88 | -4.04 | -8.26 | -73.14 | -88.10 | -127.08 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.14 | 0.08 | 0.05 | 0.06 | 0.05 | -0.50 | -0.44 | -0.55 | -0.56 | -1.08 | 8.37 | 4.91 | n/a | n/a | -0.92 |
Quick Ratio | 0.51 | 0.90 | 1.31 | 8.34 | 12.79 | 0.15 | 0.01 | 0.05 | 0.15 | 1.16 | 3.42 | 2.45 | n/a | n/a | 0.02 |
Current Ratio | 0.51 | 0.90 | 1.31 | 8.34 | 12.79 | 0.15 | 0.01 | 0.05 | 0.15 | 1.16 | 3.42 | 2.45 | n/a | n/a | 0.02 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | -1.95 | -4.74 | -32.65 | -292.69 | -115.55 | -9.58 | -7.65 | -9.19 | -19.34 | -10.10 | -41.48 | -12.87 | -3.37 | -6.83 | -7.87 |
Return on Equity | -18.95% | -27.71% | -0.75% | -21.83% | -27.34% | 22.86% | 22.95% | 31.77% | 62.94% | 112.04% | -1.78K% | -75.53% | n/a | n/a | 10.45% |
Return on Assets | -15.81% | -24.83% | -0.70% | -19.26% | -25.24% | -154.83% | -2.39K% | -900.97% | -610.03% | -187.98% | -134.33% | -11.92% | n/a | n/a | -1.21K% |
Return on Invested Capital | -5.19% | -2.99% | -4.37% | -21.29% | -26.02% | 41.08% | 36.20% | 63.23% | 136.01% | -1.28K% | -187.13% | -12.10% | n/a | n/a | 123.47% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove APUS